Skip to content
DataLookout
Menu

NCT07034586

Prospective Evaluation of Adventitial Histopathology in Borderline Ascending Aortic Dilatatio

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Study completion date changed from estimate of Sep 1, 2025 to Jun 30, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 15 words
    • Trial completed
    • Enrollment increased: 102 → 130 participants
    • Study description expanded, about 73 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Association Between Histopathological Findings and Aortic Diameter
Timeframe: Postoperative period (within 1 month)

Arms and interventions

Observational Aort Dilated Group

Patients undergoing elective coronary artery bypass grafting (CABG) with an ascending aortic diameter between 4.0 cm and 5.0 cm. These patients do not have known genetic aortopathy and are undergoing their first cardiac surgery. Aortic tissue samples are collected during surgery from the punch biopsy site used for proximal anastomosis.

Observational Control Group

Patients undergoing elective CABG with an ascending aortic diameter less than 4.0 cm. These patients also do not have known aortopathies and are undergoing their first cardiac surgery. Punch biopsy material is similarly collected for histopathological evaluation.

Sites

1 site in 1 country

  • Samsun University Faculty of MedicineSamsun, Turkey (Türkiye)